CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution - NEC
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:CFN
- CUSIP: 14170T10
- Web: www.carefusion.com
Average Prices:- 50 Day Moving Avg: $60.00
- 200 Day Moving Avg: $59.00
- 52 Week Range: $38.00 - $60.00
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 20.00
- P/E Growth: 0
Profitability:- Net Margins: 16.18%
- Return on Equity: 12.80%
- Return on Assets: 7.62%
Misc:- Average Volume: 2.71 million shs.
Frequently Asked Questions for CareFusion (NYSE:CFN)
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) announced its earnings results on Thursday, February, 5th. The company reported $0.99 EPS for the quarter, beating the Zacks' consensus estimate of $0.79 by $0.20. The firm had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.01 billion. CareFusion had a net margin of 16.18% and a return on equity of 12.80%. The company's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.54 EPS. View CareFusion's Earnings History.
Who are some of CareFusion's key competitors?
Some companies that are related to CareFusion include Baxter International (BAX), Zimmer Biomet Holdings (ZBH), C.R. Bard (BCR), DENTSPLY SIRONA (XRAY), Align Technology (ALGN), Bio-Rad Laboratories (BIO), STERIS PLC (STE), West Pharmaceutical Services (WST), DexCom (DXCM), Hill-Rom Holdings (HRC), VWR Corporation (VWR), NuVasive (NUVA), Integra LifeSciences Holdings Corporation (IART), ICU Medical (ICUI), LivaNova PLC (LIVN), Nevro Corp. (NVRO), Neogen Corporation (NEOG) and Haemonetics Corporation (HAE).
How do I buy CareFusion stock?
Shares of CareFusion can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CareFusion's stock price today?
One share of CareFusion stock can currently be purchased for approximately $60.00.
MarketBeat Community Rating for CareFusion (NYSE CFN)MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for CareFusion (NYSE:CFN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for CareFusion (NYSE:CFN)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for CareFusion (NYSE:CFN)Earnings History by Quarter for CareFusion (NYSE CFN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/5/2015 | Q215 | $0.79 | $0.99 | $1.01 billion | $1.07 billion | View | N/A |  |
| 11/6/2014 | Q115 | $0.49 | $0.50 | $920.50 million | $922.00 million | View | N/A | |
| 8/7/2014 | Q414 | $0.72 | $0.79 | $1.04 billion | $1.12 billion | View | Listen | |
| 5/5/2014 | Q314 | $0.62 | $0.60 | $986.67 million | $968.00 million | View | Listen | |
| 2/3/2014 | Q214 | $0.54 | $0.54 | $911.13 million | $922.00 million | View | Listen | |
| 8/8/2013 | Q4 2013 | $0.56 | $0.55 | $918.25 million | $903.00 million | View | Listen | |
| 5/9/2013 | Q3 2013 | $0.53 | $0.59 | $909.16 million | $901.00 million | View | Listen | |
| 8/9/2012 | | $0.50 | $0.51 | | | View | N/A | |
| 5/3/2012 | | $0.45 | $0.49 | | | View | N/A | |
| 2/2/2012 | | $0.43 | $0.44 | | | View | N/A | |
| 11/7/2011 | | $0.33 | $0.33 | | | View | N/A | |
| 8/8/2011 | | $0.50 | $0.52 | | | View | N/A | |
| 5/5/2011 | | $0.40 | $0.42 | | | View | N/A | |
| 2/3/2011 | | $0.37 | $0.44 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for CareFusion (NYSE:CFN)Current Year EPS Consensus Estimate: $3 EPS
Next Year EPS Consensus Estimate: $3 EPS
Dividend History for CareFusion (NYSE:CFN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for CareFusion (NYSE:CFN)Insider Trades by Quarter for CareFusion (NYSE:CFN)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 2/6/2015 | Jonathan Wygant | CAO | Sell | 1,700 | $59.79 | $101,643.00 | |
| 2/6/2015 | Philip L Francis | Director | Sell | 40,980 | $59.89 | $2,454,292.20 | |
| 12/15/2014 | Thomas J Leonard | Insider | Sell | 25,000 | $58.87 | $1,471,750.00 | |
| 12/4/2014 | Donald Abbey | EVP | Sell | 1,000 | $59.35 | $59,350.00 | |
| 11/12/2014 | J Michael Losh | Director | Sell | 12,630 | $57.32 | $723,951.60 | |
| 10/6/2014 | James F Hinrichs | CFO | Sell | 20,000 | $56.91 | $1,138,200.00 | |
| 10/6/2014 | Thomas J Leonard | Insider | Sell | 8,400 | $57.16 | $480,144.00 | |
| 10/1/2014 | James F Hinrichs | CFO | Sell | 20,000 | $45.07 | $901,400.00 | |
| 9/19/2014 | Thomas J Leonard | Insider | Sell | 16,600 | $47.01 | $780,366.00 | |
| 9/15/2014 | Thomas J Leonard | Insider | Sell | 25,000 | $46.17 | $1,154,250.00 | |
| 7/7/2014 | Thomas J Leonard | Insider | Sell | 1,250 | $45.47 | $56,837.50 | |
| 7/1/2014 | Thomas J Leonard | Insider | Sell | 19,721 | $45.00 | $887,445.00 | |
| 6/6/2014 | James F Hinrichs | CFO | Sell | 21,506 | $44.07 | $947,769.42 | |
| 6/2/2014 | Thomas J Leonard | Insider | Sell | 1,250 | $42.81 | $53,512.50 | |
| 5/29/2014 | Fortune Gordon La | EVP | Sell | 2,158 | $42.61 | $91,952.38 | |
| 5/20/2014 | Kieran Gallahue | CEO | Sell | 100,000 | $42.98 | $4,298,000.00 | |
| 5/19/2014 | Fortune Gordon La | EVP | Sell | 38,738 | $42.70 | $1,654,112.60 | |
| 5/19/2014 | Thomas Leonard | Insider | Sell | 30,000 | $42.89 | $1,286,700.00 | |
| 5/5/2014 | Thomas Leonard | Insider | Sell | 1,250 | $39.06 | $48,825.00 | |
| 4/7/2014 | Thomas Leonard | Insider | Sell | 1,250 | $40.05 | $50,062.50 | |
| 4/4/2014 | Donald Abbey | EVP | Sell | 10,076 | $41.79 | $421,076.04 | |
| 3/3/2014 | Thomas Leonard | Insider | Sell | 1,250 | $40.26 | $50,325.00 | |
| 2/5/2014 | Philip Francis | Director | Buy | 6,500 | $38.61 | $250,965.00 | |
| 2/5/2014 | Thomas Leonard | Insider | Sell | 21,496 | $38.24 | $822,007.04 | |
| 1/9/2014 | Kieran Gallahue | CEO | Sell | 25,000 | $41.05 | $1,026,250.00 | |
| 1/6/2014 | Thomas Leonard | Insider | Sell | 1,250 | $39.48 | $49,350.00 | |
| 12/2/2013 | James Hinrichs | CFO | Sell | 28,078 | $40.13 | $1,126,770.14 | |
| 12/2/2013 | Kieran Gallahue | CEO | Sell | 25,000 | $40.09 | $1,002,250.00 | |
| 12/2/2013 | Thomas Leonard | Insider | Sell | 1,250 | $39.99 | $49,987.50 | |
| 11/4/2013 | Thomas J Leonard | Insider | Sell | 1,250 | $39.06 | $48,825.00 | |
| 10/1/2013 | Thomas J Leonard | Insider | Sell | 1,250 | $36.99 | $46,237.50 | |
| 9/9/2013 | Fortune Gordon La | EVP | Sell | 33,960 | $36.55 | $1,241,238.00 | |
| 9/3/2013 | Thomas Leonard | Insider | Sell | 1,250 | $35.70 | $44,625.00 | |
| 8/26/2013 | J Michael Losh | Director | Sell | 53,311 | $35.67 | $1,901,603.37 | |
(Data available from 1/1/2013 forward)
Headline Trends for CareFusion (NYSE:CFN)
Latest Headlines for CareFusion (NYSE:CFN)
| Source: |
|
CareFusion (CFN) Chart for Friday, July, 28, 2017
